The Food and Drug Administration said Thursday it will ask its outside experts to meet…
View More FDA unlikely to rule on Merck’s COVID pill before December
Home »
U.S. FDA declines to approve Sesen Bio's bladder cancer treatment
(Reuters) – The U.S. Food and Drug Administration has declined to approve Sesen Bio Inc’s…
View More U.S. FDA declines to approve Sesen Bio's bladder cancer treatment
Researchers ask FDA to pull more sunscreens over possible carcinogen
Fox News Flash top headlines for August 11 Fox News Flash top headlines are here.…
View More Researchers ask FDA to pull more sunscreens over possible carcinogen
FDA Approves Octapharma’s Octagam 10% for Adult Dermatomyositis
PARAMUS, N.J.–(BUSINESS WIRE) July 20, 2021 –The U.S. Food and Drug Administration (FDA) has granted…
View More FDA Approves Octapharma’s Octagam 10% for Adult Dermatomyositis
FDA Approves Kerendia
FDA Approves Kerendia (finerenone) for the Treatment of Patients with Chronic Kidney Disease Associated with…
View More FDA Approves Kerendia
FDA Approves Camcevi
FDA Approves Camcevi (leuprolide mesylate) for the Treatment of Advanced Prostate Cancer TAIPEI, May 26,…
View More FDA Approves Camcevi
FDA approves higher-dose naloxone hydrochloride nasal spray
(HealthDay)—The U.S. Food and Drug Administration approved use of a higher dose of naloxone hydrochloride…
View More FDA approves higher-dose naloxone hydrochloride nasal spray
FDA Approves Nextstellis
FDA Approves Nextstellis (drospirenone and estetrol) Oral Contraceptive for Birth Control 15 April 2021, Adelaide,…
View More FDA Approves Nextstellis
FDA Approves Qelbree
FDA Approves Qelbree (viloxazine) for the Treatment of ADHD ROCKVILLE, Md., April 02, 2021 (GLOBE NEWSWIRE) — Supernus…
View More FDA Approves Qelbree
FDA OKs Neuromodulation Device to Improve Gait in MS
The US Food and Drug Administration (FDA) has approved the Portable Neuromodulation Stimulator (PoNS, Helius…
View More FDA OKs Neuromodulation Device to Improve Gait in MS